StockData
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. (ANTX) income statement

ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$5.08−0.14 (-2.68%)

Close on Nov 20, 2026Market cap $191.70MP/E –Yield –

See a number that looks wrong?